6-(3-(((5-CHLORO-2-METHOXY-3-PYRIDINYL)SULFONYL)AMINO)-2,6-DIFLUOROPHENYL)-N-METHYLIMIDAZO(1,5-A)PYRAZINE-1-CARBOXAMIDE
UNII TXP5VBR3XH

Substance Identification & Data

This profile provides standardized clinical and technical data for 6-(3-(((5-chloro-2-methoxy-3-pyridinyl)sulfonyl)amino)-2,6-difluorophenyl)-n-methylimidazo(1,5-a)pyrazine-1-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TXP5VBR3XH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2803470-63-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TXP5VBR3XH

CAS Registry Number

2803470-63-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

6-(3-(((5-CHLORO-2-METHOXY-3-PYRIDINYL)SULFONYL)AMINO)-2,6-DIFLUOROPHENYL)-N-METHYLIMIDAZO(1,5-A)PYRAZINE-1-CARBOXAMIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H15ClF2N6O4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KIGXQRBUVDDSPP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C222803

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

164593978

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(S(Nc2ccc(F)c(c2F)-c3cn4cnc(c4cn3)C(NC)=O)(=O)=O)c(OC)ncc1Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 6-(3-(((5-chloro-2-methoxy-3-pyridinyl)sulfonyl)amino)-2,6-difluorophenyl)-n-methylimidazo(1,5-a)pyrazine-1-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.